Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Breast cancer remains a significant cause of mortality in women worldwide.
• Metastatic relapse in breast cancer is often incurable, highlighting the need to understand disease progression mechanisms.

Purpose of the Study:

• To investigate the role of microRNA-193b (miR-193b) in breast cancer progression.
• To identify direct targets of miR-193b involved in breast cancer development.

Main Methods:

• Down-regulation of miR-193b was assessed in human breast cancer cell lines (MDA-MB-231, MCF-7).
• Functional assays (proliferation, clonogenicity, migration, invasion) were performed after miR-193b reconstitution.
• In silico prediction algorithms and luciferase reporter assays were used to identify and confirm direct targets (DNAJC13, RAB22A).

Main Results:

• miR-193b was significantly down-regulated in breast cancer cell lines.
• Restoring miR-193b expression reduced cell proliferation, clonogenicity, migration, and invasion.
• DNAJC13 and RAB22A were validated as direct targets of miR-193b, with their expression decreased upon miR-193b re-expression.

Conclusions:

• miR-193b functions as a novel tumor suppressor in breast cancer.
• The miR-193b/DNAJC13/RAB22A pathway is implicated in regulating breast cancer cell aggressiveness and progression.